HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tatsuro Mori Selected Research

Cytokines

4/2010[Case of skull metastasis from hepatocellular carcinoma at the site of skull fracture].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tatsuro Mori Research Topics

Disease

5Traumatic Brain Injuries (Traumatic Brain Injury)
04/2014 - 04/2002
4Hyponatremia
12/2012 - 12/2003
4Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2007 - 12/2003
3Edema (Dropsy)
04/2014 - 11/2002
3Wounds and Injuries (Trauma)
11/2002 - 04/2002
2Contusions
04/2014 - 05/2007
2Intracranial Vasospasm
12/2012 - 12/2007
2Ischemia
06/2005 - 11/2002
2Brain Injuries (Brain Injury)
11/2002 - 05/2002
1Necrosis
04/2014
1Neoplasm Metastasis (Metastasis)
04/2010
1Neoplasms (Cancer)
04/2010
1Wasting Syndrome (Wasting Disease)
12/2007
1Central Nervous System Diseases (CNS Diseases)
10/2007
1Craniocerebral Trauma (Head Injury)
11/2005
1Brain Ischemia (Cerebral Ischemia)
06/2005
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
06/2005
1Thrombosis (Thrombus)
06/2005
1Neurologic Manifestations (Neurological Manifestations)
06/2005
1Stroke (Strokes)
06/2005
1Reperfusion Injury
11/2002
1Brain Contusion
05/2002
1Cognitive Dysfunction
05/2002

Drug/Important Bio-Agent (IBA)

4SodiumIBA
12/2012 - 12/2003
3Hydrocortisone (Cortisol)FDA LinkGeneric
10/2007 - 12/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 04/2010
2SaltsIBA
12/2007 - 04/2005
2Tissue Plasminogen Activator (Alteplase)FDA Link
06/2005 - 11/2002
2Mitogen-Activated Protein KinasesIBA
11/2002 - 04/2002
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2002 - 04/2002
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2002 - 11/2002
2Phosphotransferases (Kinase)IBA
05/2002 - 04/2002
1EnzymesIBA
04/2014
1Evans Blue (Blue, Evans)FDA Link
04/2014
1Monoclonal AntibodiesIBA
04/2014
1ImmunosorbentsIBA
04/2014
1Bevacizumab (Avastin)FDA Link
04/2014
1Pharmaceutical PreparationsIBA
12/2012
1Therapeutic UsesIBA
12/2012
1CytokinesIBA
04/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2010
1ElectrolytesIBA
10/2007
1MineralocorticoidsIBA
10/2007
1IonsIBA
05/2007
1Colloids (Colloid)IBA
05/2007
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2005
1Simvastatin (Zocor)FDA LinkGeneric
06/2005
1Atorvastatin (Lipitor)FDA Link
06/2005
1GelatinIBA
11/2002
1U 0126 (UO 126)IBA
11/2002
1Zonula Occludens-1 ProteinIBA
11/2002
1Superoxides (Superoxide)IBA
05/2002
1AntioxidantsIBA
05/2002
1OPC 14117IBA
05/2002
1Proteins (Proteins, Gene)FDA Link
05/2002
1MitogensIBA
05/2002
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
05/2002
1Matrix Metalloproteinases (MMPs)IBA
05/2002
1JNK Mitogen-Activated Protein KinasesIBA
04/2002
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
04/2002

Therapy/Procedure

3Therapeutics
12/2012 - 12/2003
1Length of Stay
10/2007
1Hemodilution
11/2005
1Conservative Treatment
11/2005